From the Guidelines
Asymptomatic bacteriuria with Klebsiella generally does not require antibiotic treatment in most patients. Treatment is only recommended for specific populations: pregnant women and patients undergoing urologic procedures where mucosal bleeding is anticipated. For pregnant women with Klebsiella bacteriuria, appropriate antibiotics include nitrofurantoin 100mg twice daily for 5-7 days, or amoxicillin-clavulanate 500/125mg twice daily for 3-7 days, as suggested by the Infectious Diseases Society of America guidelines 1. For patients undergoing urologic procedures, a single dose of an appropriate antibiotic based on susceptibility testing should be given shortly before the procedure, as recommended by the American Urological Association 1. The reason most asymptomatic bacteriuria is left untreated is that antibiotics do not improve outcomes in most populations, while they increase the risk of adverse effects and antimicrobial resistance, as highlighted in the guideline on adult neurogenic lower urinary tract dysfunction 1. Treating asymptomatic bacteriuria can select for resistant organisms and make future infections harder to treat. If treatment is deemed necessary, antibiotic selection should always be guided by susceptibility testing, as Klebsiella species often have variable resistance patterns. Patients should be advised to maintain good hydration and proper hygiene practices regardless of whether antibiotics are prescribed.
Some key points to consider in the management of asymptomatic bacteriuria include:
- The diagnosis of asymptomatic bacteriuria should be based on results of culture of a urine specimen collected in a manner that minimizes contamination, as outlined in the Infectious Diseases Society of America guidelines 1.
- Pyuria accompanying asymptomatic bacteriuria is not an indication for antimicrobial treatment, as stated in the guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults 1.
- Screening for and treatment of asymptomatic bacteriuria is not recommended for most populations, including premenopausal, nonpregnant women, diabetic women, and older persons living in the community, as recommended by the Infectious Diseases Society of America guidelines 1.
- Antimicrobial treatment of asymptomatic women with catheter-acquired bacteriuria that persists 48 h after indwelling catheter removal may be considered, as suggested by the guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults 1.
Overall, the management of asymptomatic bacteriuria should be guided by the principles of antimicrobial stewardship, with a focus on minimizing the use of antibiotics and reducing the risk of antimicrobial resistance, as emphasized in the guideline on recurrent uncomplicated urinary tract infections in women 1.
From the FDA Drug Label
INDICATIONS AND USAGE Ciprofloxacin Tablets USP, 250 mg, 500 mg and 750 mg is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. Adult Patients: Urinary Tract Infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, Proteus mirabilis, Providencia rettgeri, Morganella morganii, Citrobacter diversus, Citrobacter freundii, Pseudomonas aeruginosa, methicillin-susceptible Staphylococcus epidermidis, Staphylococcus saprophyticus, or Enterococcus faecalis Urinary Tract Infections For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis and Proteus vulgaris
The FDA drug label does not provide specific recommendations for antibiotic treatment in patients with asymptomatic bacteriuria (ASB) due to Klebsiella pneumoniae in the urine. The labels only discuss the treatment of urinary tract infections, which implies the presence of symptoms.
- Key points:
- The labels do not address asymptomatic bacteriuria.
- Ciprofloxacin and Trimethoprim-sulfamethoxazole are indicated for the treatment of urinary tract infections caused by Klebsiella pneumoniae, but only in the presence of symptoms.
- No conclusion can be drawn regarding the treatment of asymptomatic bacteriuria due to Klebsiella pneumoniae based on the provided drug labels 2 3.